Founded SurgoCap in 2021 with $1.8B, now ~$6B AUM. Spent 23 years as founding partner at Lone Pine Capital, one of the most successful hedge funds. Focuses on concentrated, long-duration moats across enterprise data/tech, financial services, healthcare services, and industrial technologies. Uses data-science debiasing and private-market access.
TSMC owns not just the leading-edge fab but the entire process-engineering ecosystem around chip manufacturing, creating a systemic moat that is hard to replicate.
Inference is the annuity stream of AI; application-specific chips (ASICs/TPUs) built for inference workloads create very long-duration moats. Gaonkar missed the full move after selling in 2015 due to crypto/gaming headwinds and failed to revisit due to sunk-cost bias.
Only early innings of robotic surgery adoption across ~300M global surgeries; combination of haptic feedback, mapping software, and surgical workflow integration drives lower error rates and easier training.